Docoh
Loading...

TXG 10x Genomics

News

From Benzinga Pro
Notable 10X Genomics Insider Trades $2.7M In Company Stock
15 Oct 21
News, Insider Trades, Trading Ideas
Bradford Crutchfield, Chief Commercial Officer at 10X Genomics (NASDAQ:TXG), made a large buy and sell of company shares on October 12, according to a new SEC filing.
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2021
16 Sep 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Why 10x Genomics Shares Are Trading Lower Today
14 Sep 21
News, Downgrades, Analyst Ratings, Trading Ideas
10x Genomics (NASDAQ:TXG) shares are trading lower after B of A Securities downgraded the stock from Buy to Neutral and announced a $180 price target.
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2021
14 Sep 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
B of A Securities Downgrades 10x Genomics to Neutral, Announces $180 Price Target
14 Sep 21
News, Downgrades, Price Target, Analyst Ratings
B of A Securities analyst Derik De Bruin downgrades 10x Genomics (NASDAQ:TXG) from Buy to Neutral and announces $180 price target.
Looking into 10x Genomics's Return on Capital Employed
20 Aug 21
Earnings
Pulled from Benzinga Pro data 10x Genomics (NASDAQ:TXG) reported Q2 sales of $115.84 million. Earnings fell to a loss of $10.33 million, resulting in a 1.1% decrease from last quarter.
Cathie Wood's ARK Invest Posts Fund Sales For Tuesday, Aug. 17, 2021: SRPT, RHHBY, REGN, NVS, TXG, SHOP, DOCU, SE, PRLB, NTDOY, NSTG, MCRB, IOVA, XONE, BYDDY, BIDU, ANSS, NVDA, TRMB
18 Aug 21
Hedge Funds, Trading Ideas, General
Sarepta Therapeutics (SRPT) - 33,751 Shares Roche (RHHBY) - 100,262 Regneron Pharmaceuticals (REGN) - 25,962 Novartis (NVS) - 30,729 10x Genomics (TXG) - 65,754 Shopify (SHOP) - 9,793 DocuSign (DOCU) -
Cathie Wood's ARK Invest Posts Fund Sales For Tuesday, Aug. 10, 2021: SEER, TAK, RHHBY, REGN, PSTG, NVS, CLLS, BMY, TXG, SQ, SHOP, SE, NTDOY, MCRB, DOCU, NVDA, NFLX, BABA
11 Aug 21
Hedge Funds, Trading Ideas, General
Seer (SEER) - 121,042 Shares Takeda Pharmaceutical (TAK) - 116,467 Roche (RHHBY) - 394,655 Regeneron Pharmaceuticals (REGN) - 7,402 Pure Storage (PSTG) - 136,940 Novartis (NVS) - 53,188 Cellectis (CLLS) -
Citigroup Maintains Buy on 10x Genomics, Lowers Price Target to $220
5 Aug 21
News, Price Target, Analyst Ratings
Citigroup analyst Patrick Donnelly maintains 10x Genomics (NASDAQ:TXG) with a Buy and lowers the price target from $240 to $220.
Earnings Scheduled For August 5, 2021
5 Aug 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
10x Genomics Q2 EPS $(0.10) Beats $(0.26) Estimate, Sales $115.85M Beat $112.85M Estimate; Reaffirms FY21 Sales Guidance $480M-$500M vs $496.5M Est.
4 Aug 21
Earnings, News, Guidance
10x Genomics (NASDAQ:TXG) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.26) by 61.54 percent. This is a 75.61 percent increase over losses of $(0.41) per share from the
12 Health Care Stocks Moving In Wednesday's After-Market Session
4 Aug 21
Movers
Gainers
Earnings Scheduled For August 4, 2021
4 Aug 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.